Company news

Share this article:
Merck has ended a research collaboration agreement with Surmodics Inc, a drug delivery systems provider. The decision is not based on safety or efficacy concerns of Surmodic's systems, according to a Merck statement.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions